Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Jiuding Pharmaceutical is a comprehensive pharmaceutical company based in China, specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company focuses on high-prevalence therapeutic areas, including cardiovascular disease, metabolic disorders, and anti-infectives. Jiuding is recognized for its large-scale production of essential generic medications such as atorvastatin, rosuvastatin, and clopidogrel, serving both the domestic Chinese market and international clients. Its manufacturing facilities are GMP-certified, ensuring compliance with rigorous quality standards for global distribution. In addition to its product portfolio, the company provides contract development and manufacturing (CDMO) services to the broader pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiuding Pharmaceuticals.